These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2885985)

  • 1. [Clinical studies with salazopyrine--consequences and perspectives].
    Zeidler H
    Z Rheumatol; 1987; 46(2):59-66. PubMed ID: 2885985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of sulphasalazine--a review.
    Capell HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ
    J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis: disease-modifying antirheumatic drugs.
    Kirwan JR; Currey HL
    Clin Rheum Dis; 1983 Dec; 9(3):581-99. PubMed ID: 6360514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the disease activity score in the analysis of clinical trials in rheumatoid arthritis.
    Fuchs HA
    J Rheumatol; 1993 Nov; 20(11):1863-6. PubMed ID: 7905924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sulfasalazine or salazosulfapyridine in the treatment of rheumatoid polyarthritis. An open study of 46 patients. Review of the literature].
    Trèves R; Morvan C; Bitaudeau P; Clément S; Liozon E; Arnaud M; Archambeaud-Mouveroux F; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1988; 55(9):641-6. PubMed ID: 2903546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid spondylarthritis with salazosulfapyridine].
    Hilliquin P; Munoz A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1991; 58(7):535-41. PubMed ID: 1681585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of rheumatoid arthritis--rationale and overview.
    Jaffe IA
    J Rheumatol Suppl; 1990 Nov; 25():24-7. PubMed ID: 1980314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of rheumatoid polyarthritis using salazosulfapyridine (Salazopyrine). A 6-month open study of 34 patients].
    Ghozlan R; Dupuis M; Schwak A; Jorro P; Lecarpentier C; Guillon C
    Rev Rhum Mal Osteoartic; 1988 Feb; 55(2):127-30. PubMed ID: 2895959
    [No Abstract]   [Full Text] [Related]  

  • 17. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
    Situnayake RD; Grindulis KA; McConkey B
    Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.
    Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA
    J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.